durvalumab
astrazeneca
['durvalumab', 'lung']
mandy moore, pharmd, phd candidate at the is presenting our research on durvalumab for patients with stage iii unresectable non-small cell lung cancer in chicago, il today. way to go mandy! 
UT Austin & UT Health San Antonio Professor of Pharmacy & Medicine, Director of Translational Science PhD and TL1 Programs, Proud Father of Alexa & Andrew Frei